Product Information
FESOTERODINE ER 4 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.7938 per EA under NDC 72603041301. Its NADAC has been published 113 times since Aug 7, 2024.
FDA first approved this application on Jan 9, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
NorthStar Rx LLCNDC
72603041301
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FESOTERODINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA204792FDA Approved
1/9/2024
TE Code
AB
On Market Since
5/1/2024
Price Statistics
The NADAC for FESOTERODINE ER 4 MG TABLET has been published 113 times since Aug 7, 2024, and over the history we have for it it has risen 22.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7938 per EA |
|---|---|
| All-time high | $0.9304 (Dec 10, 2025) |
| All-time low | $0.6489 (Aug 7, 2024) |
| 52-week high | $0.9304 |
| 52-week low | $0.7896 |
| Median price | $0.8513 |
| Average price | $0.8521 |
| Largest weekly change | +43.2% (Aug 21, 2024) |
| Weeks tracked | 113 |
| Tracking since | Aug 7, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
FESOTERODINE FUMARATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FESOTERODINE ER 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FESOTERODINE ER 4 MG TABLET, manufactured by NorthStar Rx LLC, is $0.7938 per EA (NDC 72603041301), effective Sep 30, 2026.
How has the price of FESOTERODINE ER 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for FESOTERODINE ER 4 MG TABLET has risen 22.3%. It has been tracked across 113 weekly CMS publications since Aug 7, 2024.
What are the highest and lowest recorded NADAC prices for FESOTERODINE ER 4 MG TABLET?
Since Aug 7, 2024, the NADAC for FESOTERODINE ER 4 MG TABLET has ranged from a low of $0.6489 (Aug 7, 2024) to a high of $0.9304 (Dec 10, 2025), with a median of $0.8513 per EA.
Are there cheaper alternatives to FESOTERODINE ER 4 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FESOTERODINE ER 4 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FESOTERODINE ER 4 MG TABLET?
FESOTERODINE ER 4 MG TABLET (NDC 72603041301) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.